174 related articles for article (PubMed ID: 38820767)
1. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo.
Cao Q; Fang H; Tian H
Biomaterials; 2024 Oct; 310():122628. PubMed ID: 38820767
[TBL] [Abstract][Full Text] [Related]
2. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
Jordan SC
Clin Exp Immunol; 2021 Jun; 204(3):310-320. PubMed ID: 33534923
[TBL] [Abstract][Full Text] [Related]
3. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans.
Hellgren F; Rosdahl A; Arcoverde Cerveira R; Lenart K; Ols S; Gwon YD; Kurt S; Delis AM; Joas G; Evander M; Normark J; Ahlm C; Forsell MN; Cajander S; Loré K
JCI Insight; 2024 May; 9(9):. PubMed ID: 38716734
[TBL] [Abstract][Full Text] [Related]
4. Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA.
Zimmermann L; Erbar S
Methods Mol Biol; 2024; 2786():135-144. PubMed ID: 38814392
[TBL] [Abstract][Full Text] [Related]
5. Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.
Saresella M; Piancone F; Marventano I; Hernis A; Trabattoni D; Invernizzi M; La Rosa F; Clerici M
Front Immunol; 2022; 13():947320. PubMed ID: 36072604
[TBL] [Abstract][Full Text] [Related]
6. Cancer mRNA vaccines: clinical advances and future opportunities.
Sayour EJ; Boczkowski D; Mitchell DA; Nair SK
Nat Rev Clin Oncol; 2024 Jul; 21(7):489-500. PubMed ID: 38760500
[TBL] [Abstract][Full Text] [Related]
7. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.
Minnaert AK; Vanluchene H; Verbeke R; Lentacker I; De Smedt SC; Raemdonck K; Sanders NN; Remaut K
Adv Drug Deliv Rev; 2021 Sep; 176():113900. PubMed ID: 34324884
[TBL] [Abstract][Full Text] [Related]
8. mRNA Vaccine Nanoplatforms and Innate Immunity.
Wei L; Dong C; Zhu W; Wang BZ
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257820
[TBL] [Abstract][Full Text] [Related]
9. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
10. Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook.
Verma A; Awasthi A
Curr Pharm Des; 2024; 30(14):1049-1059. PubMed ID: 38551046
[TBL] [Abstract][Full Text] [Related]
11. Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
Tomalka JA; Suthar MS; Deeks SG; Sekaly RP
Nat Immunol; 2022 Mar; 23(3):360-370. PubMed ID: 35210622
[TBL] [Abstract][Full Text] [Related]
12. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs.
Seneff S; Nigh G; Kyriakopoulos AM; McCullough PA
Food Chem Toxicol; 2022 Jun; 164():113008. PubMed ID: 35436552
[TBL] [Abstract][Full Text] [Related]
13. Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
Chumakov K; Avidan MS; Benn CS; Bertozzi SM; Blatt L; Chang AY; Jamison DT; Khader SA; Kottilil S; Netea MG; Sparrow A; Gallo RC
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006644
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2.
Salleh MZ; Norazmi MN; Deris ZZ
PeerJ; 2022; 10():e13083. PubMed ID: 35287350
[TBL] [Abstract][Full Text] [Related]
15. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
16. Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.
Zhang C; Wang Y; Peng J; Wen X; Zhang Y; Li K; Du H; Hu X
Hum Vaccin Immunother; 2024 Dec; 20(1):2355037. PubMed ID: 38813652
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
Ansariniya H; Seifati SM; Zaker E; Zare F
Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
[TBL] [Abstract][Full Text] [Related]
18. From mRNA sensing to vaccines.
Fauci AS; Merad M; Swaminathan S; Hur S; Topol E; Fitzgerald K; Reis e Sousa C; Corbett KS; Bauer S
Immunity; 2021 Dec; 54(12):2676-2680. PubMed ID: 34739870
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 mRNA vaccines.
Huang Q; Zeng J; Yan J
J Genet Genomics; 2021 Feb; 48(2):107-114. PubMed ID: 34006471
[TBL] [Abstract][Full Text] [Related]
20. Innate sensing of mRNA vaccines.
Wuebben C; Bartok E; Hartmann G
Curr Opin Immunol; 2022 Dec; 79():102249. PubMed ID: 36334350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
